Press Releases Celgene

Equities

CELG

Delayed Nasdaq Other stock markets 04:00:00 2019-11-20 pm EST			5-day change	1st Jan Change
108.2 ^USD	+0.10%		-1.97%	+68.89%

2023	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
2021	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	23-02-28	AQ
Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia	22-08-24	AQ
Authorisation request for proposed settlement between pharmaceutical companies withdrawn	22-07-29	AQ
BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	22-02-24	AQ
Celgene : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®)	21-08-04	AQ
Besra Gold Inc: Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder Meeting	21-07-09	NE
Celgene : Rocket docket pharma patent litigation taking off in Australia and other emerging trends	21-04-14	AQ
DGAP-WpÜG: Tender Offer / Target company: ; Bidder: qqqqq	21-04-07	EQ
Cadila Healthcare Limited : - Zydus Announces Settlement of Patent Litigation for Generic Revlimid in U.S.	21-03-25	AQ
Leonteq becomes new issuer on BX Swiss – “deriBX”	21-03-25	TE
BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	21-02-23	AQ
Bristol Myers Squibb : and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at 'Make Whole' Prices	21-02-23	AQ
MEI Pharma : Appoints Brian T. Powl As Senior Vice President Marketing	20-09-16	AQ
BX Swiss AG receives approval from FINMA as Swiss Client Advisor Register	20-07-07	TE
Celgene : Parts Of Amended Patented Medicines Regulations Related To The PMPRB Struck Down	20-07-03	AQ
Furniture company mömax will be the new anchor tenant in the Rüti Center in Pratteln	20-07-03	TE
Celgene V. Sun Pharma Global: Satisfying Subject Matter Jurisdiction Under § 271(e)(2)	20-06-29	AQ
BX Swiss AG uses Blockchain technology to protect approved securities prospectuses against falsification	20-06-18	TE
BX Swiss AG receives approval from FINMA as a Prospectus Review Office	20-05-28	TE
Celgene : Announces Plans to Transfer Listing of Celgene's Contingent Value Rights Following Closing of Acquisition by Bristol-Myers Squibb	19-11-22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Celgene

Equities

CELG

Press Releases

Filters